HealthTech

How Ultrahuman is battling to break its dependency on the smart ring and the US

Shivani Verma

October 28, 2025 | 14 Min Read

Once touted as India’s answer to Finnish wearable major Oura, Ultrahuman now faces its toughest test yet—a US sales ban on its flagship product, high replacement rates, and pressure to prove it’s more than a one-product, one-market company.

When Ultrahuman launched its smart ring in 2022, it wasn’t just another wearable.

The “world’s most advanced metabolic tracker,” as it called itself, struck a chord with health-conscious users worldwide with its sleek, titanium build and aesthetic design. And its biggest following came in the US, the world’s largest smart ring market. Clocking nearly a million units annually, the US accounts for roughly a third of global smart ring sales, and is more than double the Asia-Pacific numbers.

For Ultrahuman, it was a breakthrough. Once known for its glucose sensors, the Ultrahuman M1, the company soon found itself on the shelves of Best Buy and Walmart, competing with global giants like Oura and Apple. It was hailed as the first Indian competitor to Finnish pioneer Oura, the company that made smart rings popular.

Corporate

Access unlimited content at a special discounted rate. Trusted by top VC’s and leading organizations, we provide bulk subscriptions for groups of 30+. Contact us for more details

Campus

Top educational institutions have collaborated with us for campus-wide subscriptions. For bulk campus-wide access, please get in touch.

Join our community of 100,000+ top executives, VCs, entrepreneurs, and brightest student minds

Trusted by the best

Karthik Reddy

Blume Ventures

The CapTable brings a refreshing set of insights for us at the Blume team, highlighting stories that bring together the underlying business and founders with that of investors' journeys with these startups. It's an important perspective that very few bring to startup ecosystem enthusiasts.

Latest Articles

Inside India’s GCC real estate rush: What’s fuelling the 100M sq ft opportunity

India’s office market is riding a GCC boom, with global firms leasing over 100 mn sq. ft since FY22. These firms now drive half of all office occupancy, expanding beyond tech into BFSI, manufacturing, pharma and life sciences, and tilting India’s commercial real estate map southward.

Sohini Mitter

India’s digital marketplaces are growing by going smaller

From Meesho’s zero-commission model to ride-hailing’s latest experiments, the next phase of growth, and even profits, in digital commerce may lie in serving smaller-ticket users—not chasing higher-value ones.

Pranav Balakrishnan

India’s space race moves from launchpad to ledger

Rocket launches were just act one. Now Indian spacetech founders and investors are chasing what happens in orbit: navigation systems, microgravity labs, satellite servicing, and business models that can turn presence in space into profit on Earth.

Ishan Patra

Will the cough syrup crisis finally push India to reform drug regulations?

Repeated tragedies from diethylene glycol–laced syrups reveal the cost of regulatory gaps in a booming but weakly monitored market. India can learn from the US response to a similar tragedy in 1937.

Anuj Suvarna

Decoding Meesho’s DRHP: a solid ecommerce story, but does it have a strong public market one?

Meesho filed its DRHP just as it overtook Flipkart to become India’s largest ecommerce platform by order volume. But beyond its well-established ecommerce success, the company’s new bets in logistics, fintech, and content creation still look too early-stage to move the growth needle significantly.

Team Captable

Convinced that The Captable stories and insights
will give you the edge?

Convinced that The Captable stories
and insights will give you the edge?

Subscribe Now

Stories

Explore